CLINICAL_TRIALS
trial_result
· 2016-03-15
Clinical Trial Update: OpT2mise Glucose Control in Type 2 Diabetes Mellitus (DM) With Insulin Pump Therapy [NA]
Summary
A completed clinical trial evaluated OpT2mise glucose control in Type 2 diabetes mellitus using insulin pump therapy; results were posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Medtronic MiniMed, Inc. | Conditions: Diabetes Mellitus, Type 2 | NA | Status: COMPLETED | Results posted: 2016-03-15